A troubled vaccine manufacturer, Emergent BioSolutions, announces a shake-up while projecting record revenues.


By BY SHERYL GAY STOLBERG AND CHRIS HAMBY from NYT World https://ift.tt/3nxovoJ

Post a comment

0 Comments